Asparaginase erwinia chrysanthemi Intramuscular and Rituximab Intravenous

• Generic Name: asparaginase erwinia chrysanthemi
• Dosage Forms: n.a.
• Other Brand Names: Erwinaze

Asparaginase Erwinia chrysanthemi is used together with other cancer medicines to treat a certain type of blood cancer called acute lymphoblastic leukemia (ALL). Asparaginase erwinia chrysanthemi is used in patients who have had an allergic reaction to E. coli-derived asparaginase.

Asparaginase Erwinia chrysanthemi belongs to the group of medicines known as antineoplastic agents. It interferes with the growth of the cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by asparaginase erwinia chrysanthemi, other effects will also occur. Some of these may be serious and must be reported to your doctor.

Before you begin treatment with Erwinaze®, you and your doctor should talk about the benefits of asparaginase erwinia chrysanthemi as well as the risks of using it.

Asparaginase erwinia chrysanthemi is to be given only by or under the immediate supervision of your doctor.

• Generic Name: rituximab
• Dosage Forms: n.a.
• Other Brand Names: Rituxan, Truxima

Rituximab injection is used alone or together with other medicines to treat a type of cancer called non-Hodgkin's lymphoma (NHL). It helps the immune system destroy cancer cells. Rituximab injection is a monoclonal antibody.

Rituximab injection is used together with other medicines (eg, fludarabine cyclophosphamide) to treat chronic lymphocytic leukemia (CLL).

Rituximab injection is used together with methotrexate to treat the symptoms of rheumatoid arthritis. It helps to keep joint damage from getting worse after other medicines (eg, adalimumab, etanercept, or infliximab) did not work well.

Rituximab injection is used together with steroids to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). These are immune disorders that cause blood vessels to be inflamed.

Rituximab injection is also used to treat moderate to severe pemphigus vulgaris (PV), an immune disorder that causes painful blisters on the skin and mucous membranes.

Rituximab is to be administered only by or under the direct supervision of your doctor.